Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

322

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Epilepsy
Interventions
DRUG

Lacosamide

50 mg and 100 mg Lacosamide tablets taken for 50 -400 mg twice daily dosing for up to 2 years

Trial Locations (108)

Unknown

048, Alabaster

010, Birmingham

042, Northport

009, Phoenix

014, Phoenix

151, Phoenix

103, Tucson

102, Jonesboro

007, Little Rock

086, Little Rock

120, La Habra

059, Los Angeles

021, Santa Monica

107, Torrance

060, Aurora

025, Fairfield

094, Doral

108, Gainesville

123, Miami

132, Miami

077, Orlando

049, Panama City

129, Port Charlotte

050, Sarasota

004, Tallahassee

079, Atlanta

058, Boise

131, Hines

146, Peoria

011, Springfield

078, Indianapolis

073, Ames

124, Manhattan

023, Wichita

160, Wichita

164, Lexington

062, Louisville

029, Scarborough

020, Baltimore

034, Baltimore

065, Pikesville

137, Waldorf

041, Detroit

030, Golden Valley

071, Hattiesburg

031, Chesterfield

066, St Louis

017, Lebanon

067, Voorhees Township

036, Albany

083, Buffalo

069, Cedarhurst

027, New York

122, New York

003, Asheville

063, Durham

117, Wilmington

015, Cleveland

061, Columbus

002, Toledo

147, Oklahoma City

100, Greensburg

032, Philadelphia

024, Beaufort

114, Chattanooga

001, Nashville

138, Austin

022, Dallas

046, El Paso

051, Houston

053, Houston

098, San Antonio

136, Layton

161, Alexandria

016, Charlottesville

074, Renton

080, Madison

421, Capmerdown

425, Chatswood

423, Herston

420, Adelaide

427, Parkville

140, Halifax

116, Hamilton

093, London

091, Greenfield Park

110, Montreal

113, Montreal

127, Calgary

223, Aarhus

461, Mainz

443, Ferrara

445, Reggio Calabria

447, Torrette Di Ancona

284, Częstochowa

286, Gdansk

282, Gdynia

280, Krakow

290, Lublin

289, Szczecin

281, Warsaw

287, Warsaw

324, Santa Cruz de Tenerife

360, Blackpool

367, Cornwall

364, London

369, London

363, Middlesbrough

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY